文献速递妇科生殖医学

针刺与二甲双胍对多囊卵巢综合征伴胰岛素抵抗女性胰岛素敏感性的影响:三臂随机对照试验

Effect of acupuncture and metformin on insulin sensitivity in women with polycystic ovary syndrome and insulin resistance: a three-armed randomized controlled trial.
PubMed 文献 · Hum Reprod · 2022-01-01

该三臂随机对照试验纳入342例多囊卵巢综合征(PCOS)伴胰岛素抵抗(IR)女性,比较真针刺、二甲双胍和假针刺对胰岛素敏感性的改善效果。治疗4个月后,真针刺组HOMA-IR变化为-0.5(降低14.7%),二甲双胍组为-1.0(降低25.0%),假针刺组为-0.3(降低8.6%)。真针刺改善HOMA-IR的效果不及二甲双胍(差值0.6,95%CI 0.1-1.1),但与假针刺无显著差异。

要点

  • 在PCOS伴IR女性中,真针刺改善HOMA-IR的效果不及二甲双胍(差值0.6,95%CI 0.1-1.1)。
  • 真针刺与假针刺在改善HOMA-IR上无显著差异(差值-0.2,95%CI -0.7至0.3)。
  • 二甲双胍组胃肠道不良反应更常见,真针刺组瘀斑更常见(14.9%)。

核心结论

  • 在PCOS伴IR女性中,针刺改善胰岛素敏感性的效果不及二甲双胍,但与假针刺相比无显著差异。
  • 作者认为针刺在改善糖代谢方面优于二甲双胍且副作用较少,可能作为低风险的非药物治疗,但需进一步研究评估针刺联合二甲双胍对胰岛素敏感性的影响。

研究设计与样本

  • 三臂随机对照试验,2015年11月至2018年2月从三家医院纳入342例PCOS伴IR女性,随访至2018年10月。
  • 纳入18至40岁、HOMA-IR≥2.14的PCOS伴IR女性,随机分为真针刺加安慰剂组、二甲双胍加假针刺组和假针刺加安慰剂组,每组114例。
  • 真针刺或假针刺每周3次,二甲双胍0.5g或安慰剂每日3次,治疗4个月,额外随访3个月。

主要发现

  • 治疗4个月后,HOMA-IR较基线变化:真针刺组-0.5(降低14.7%),二甲双胍组-1.0(降低25.0%),假针刺组-0.3(降低8.6%)。
  • 真针刺改善HOMA-IR不及二甲双胍(差值0.6,95%CI 0.1-1.1);真针刺与假针刺无显著差异(差值-0.2,95%CI -0.7至0.3)。
  • 治疗4个月内,二甲双胍组胃肠道副作用更常见:腹泻31.6%、恶心13.2%、食欲减退11.4%、乏力8.8%、呕吐14.0%、胃部不适8.8%。
  • 真针刺组瘀斑更常见(14.9%)。

临床怎么用

  • 作者认为针刺在改善糖代谢方面优于二甲双胍且副作用较少,可能作为PCOS伴IR女性低风险的非药物治疗。
  • 作者建议进一步研究评估针刺联合二甲双胍对这些女性胰岛素敏感性的影响。

局限性

  • 本研究可能低估了真针刺组治疗4个月时的样本量,以检测固定针刺方案(即非个体化方案)下HOMA-IR的统计学显著变化。
  • 因妊娠退出的参与者未进行后续血液检测,可能引入偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does acupuncture improve insulin sensitivity more effectively than metformin or sham acupuncture in women with polycystic ovary syndrome (PCOS) and insulin resistance (IR)? SUMMARY ANSWER: Among women with PCOS and IR, acupuncture was not more effective than metformin or sham acupuncture in improving insulin sensitivity. WHAT IS KNOWN ALREADY: Uncontrolled trials have shown that acupuncture improved insulin sensitivity with fewer side effects compared with metformin in women with PCOS and IR. However, data from randomized trials between acupuncture and metformin or sham acupuncture are lacking. STUDY DESIGN, SIZE, DURATION: This was a three-armed randomized controlled trial enrolling a total of 342 women with PCOS and IR from three hospitals between November 2015 and February 2018, with a 3-month follow-up until October 2018. PARTICIPANTS/MATERIALS, SETTING, METHODS: Women aged from 18 to 40 years with PCOS and homeostasis model assessment of insulin resistance (HOMA-IR) ≥2.14 were randomly assigned (n = 114 per group) to receive true acupuncture plus placebo (true acupuncture), metformin plus sham acupuncture (metformin, 0.5 g three times daily) or sham acupuncture plus placebo (sham acupuncture) for 4 months, with an additional 3-month follow-up. True or sham acupuncture was given three times per week, and 0.5 g metformin or placebo was given three times daily. The primary outcome was change in HOMA-IR from baseline to 4 months after baseline visit. Secondary outcomes included changes in the glucose AUC during an oral glucose tolerance test, BMI and side effects at 4 months after baseline visit. MAIN RESULTS AND THE ROLE OF CHANCE: After 4 months of treatment, the changes of HOMA-IR were -0.5 (decreased 14.7%) in the true acupuncture group, -1.0 (decreased 25.0%) in the metformin group and -0.3 (decreased 8.6%) in the sham acupuncture group, when compared with baseline. True acupuncture is not as effective as metformin in improving HOMA-IR at 4 months after baseline visit (difference, 0.6; 95% CI, 0.1-1.1). No significant difference was found in change in HOMA-IR between true and sham acupuncture groups at 4 months after baseline visit (difference, -0.2; 95% CI, -0.7 to 0.3). During the 4 months of treatment, gastrointestinal side effects were more frequent in the metformin group, including diarrhea, nausea, loss of appetite, fatigue, vomiting and stomach discomfort (31.6%, 13.2%, 11.4%, 8.8%, 14.0% and 8.8%, respectively). Bruising was more common in the true acupuncture group (14.9%). LIMITATIONS, REASONS FOR CAUTION: This study might have underestimated the sample size in the true acupuncture group with 4 months of treatment to enable detection of statistically significant changes in HOMA-IR with fixed acupuncture (i.e. a non-personalized protocol). Participants who withdrew because of pregnancy did not have further blood tests and this can introduce bias. WIDER IMPLICATIONS OF THE FINDINGS: True acupuncture did not improve insulin sensitivity as effectively as metformin in women with PCOS and IR, but it is better than metformin in improving glucose metabolism (which might reduce the risk of type 2 diabetes) and has less side effects. Metformin had a higher incidence of gastrointestinal adverse effects than acupuncture groups, and thus acupuncture might be a non-pharmacological treatment with low risk for women with PCOS. Further studies are needed to evaluate the effect of acupuncture combined with metformin on insulin sensitivity in these women. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by grants 2017A020213004 and 2014A020221060 from the Science and Technology Planning Project of Guangdong Province. The authors have no conflicts of interest. TRIAL REGISTRATION NUMBER: Clinicaltrials.gov number: NCT02491333. TRIAL REGISTRATION DATE: 8 July 2015. DATE OF FIRST PATIENT’S ENROLLMENT: 11 November 2015.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Wen Q, Hu M, Lai M, et al. Effect of acupuncture and metformin on insulin sensitivity in women with polycystic ovary syndrome and insulin resistance: a three-armed randomized controlled trial. Hum Reprod. 2022. PMID: 34907435. doi:10.1093/humrep/deab272

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。